![](/img/cover-not-exists.png)
Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients
Sánchez-Muñoz, A., Plata-Fernández, Y., Fernández, M., Jaén-Morago, A., Fernández-Navarro, M., de la Torre-Cabrera, C., Ramirez-Tortosa, C., Pascual, J., Alba, E., Sánchez-Rovira, P.Volume:
16
Language:
english
Journal:
Clinical and Translational Oncology
DOI:
10.1007/s12094-013-1116-z
Date:
June, 2014
File:
PDF, 187 KB
english, 2014